Manelimab (Anti-B7-H1 / PD-L1 / CD274)

Manelimab (Anti-B7-H1 / PD-L1 / CD274) is a monoclonal antibody directed against the immunosuppressive ligand programmed cell death-1 ligand 1 (PD-L1; cluster of differentiation 274; CD274), with potential immune checkpoint inhibitory and antineoplastic activities. MW: 143.68 kD.

• Supplier: Selleck Chemicals
• Product #: A2780
• Sku #: A2780-1mg